Cardio-Oncology: Cancer Treatment and Your Heart

Clinical Trial Finder

This Clinical Trial Finder can help you—or a loved one—easily find ongoing cardiovascular clinical research trials for which you might qualify. This list is a service of the U.S. National Institutes of Health called clinicaltrials.gov, a database of publicly and privately supported clinical studies.

Simply click on the trial below that interests you to learn how you might participate.

CARdiac Function Evaluation in Breast Cancer Patients

Condition:   Breast Cancer Female
Intervention:  
Sponsors:   Swansea University;   Abertawe Bro Morgannwg University Health Board
Active, not recruiting

Cancer Rehabilitation in Primary Health Care

Conditions:   Cancer Survivors;   All Cancers
Intervention:   Other: Complex cancer rehabilitation
Sponsors:   University of Bergen;   Norwegian Extra Foundation for Health and Rehabilitation;   Askøy Municipality
Active, not recruiting

Effect of Angiotensin Converting Enzyme and Sacubitril Valsartan in Patients After Bone Marrow Transplantation

Conditions:   Hematopoietic Stem Cell Transplantation;   Cardiotoxicity
Intervention:   Drug: ACE inhibitor, Sacubitril-Valsartan
Sponsor:   University of Athens
Recruiting

Remote Ischaemic Preconditioning in Childhood Cancer

Condition:   Cardiotoxicity
Interventions:   Procedure: Remote Ischaemic Preconditioning;   Other: Control
Sponsor:   The University of Hong Kong
Recruiting

Feasibility of an Adapted Physical Activity Program for Patients Treated With an Autograft (APA²)

Conditions:   Myeloma;   Lymphoma;   Autologous Transplant
Intervention:   Other: Adapted Physical Activity
Sponsor:   Weprom
Not yet recruiting

AMPLE-3: IPC Plus Talc vs VATS in Management of Malignant Pleural Effusion

Conditions:   Malignant Pleural Effusion;   Respiratory Disease;   Cancer
Interventions:   Procedure: Pleurodesis via Video-assisted thoracoscopic surgery;   Device: Indwelling pleural catheter (with talc pleurodesis if suitable)
Sponsors:   The University of Western Australia;   Sir Charles Gairdner Hospital;   Fiona Stanley Hospital, Australia;   The Sutherland and St George Hospitals, Australia;   Hollywood Private Hospital, Australia;   Wellington Hospital;   Northern Hospital, Australia;   Concord Hospital;   Royal Adelaide Hospital;   St John of God Midland Hospital, Australia;   St John of God Murdoch Hospital, Australia;   St John of God Subiaco Hospital, Australia;   St Vincent's Hospital Melbourne;   The Prince Charles Hospital;   Sunshine Coast Hospital and Health Service;   Guy's and St Thomas' NHS Foundation Trust;   Toronto General Hospital
Recruiting

Hartmanns Procedure or Abdominoperineal Excision With Intersphincteric Dissection in Rectal Cancer: a Randomized Study

Conditions:   Rectal Cancer;   Sphincter Ani Incontinence;   Other Diagnoses, Comorbidities, and Complications
Interventions:   Procedure: APE with intersphincteric dissection;   Procedure: Hartmann´s procedure
Sponsor:   Region Västmanland
Recruiting

A Study of Neoadjuvant Atezolizumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Patients With Resectable Stage II, IIIA, or Select IIIB Non-Small Cell Lung Cancer (IMpower030)

Condition:   Non-Small-Cell Lung
Interventions:   Drug: Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody;   Drug: Placebo Comparator;   Drug: Nab-paclitaxel;   Drug: Pemetrexed;   Drug: Carboplatin;   Drug: Cisplatin;   Drug: Gemcitabine
Sponsor:   Hoffmann-La Roche
Recruiting

A Study Comparing Adjuvant Alectinib Versus Adjuvant Platinum-Based Chemotherapy in Patients With ALK Positive Non-Small Cell Lung Cancer

Condition:   Carcinoma, Non-Small-Cell Lung
Interventions:   Drug: Alectnib;   Drug: Cisplatin;   Drug: Vinorelbine;   Drug: Gemcitabine;   Drug: Pemetrexed;   Drug: Carboplatin
Sponsor:   Hoffmann-La Roche
Recruiting

A Study of Atezolizumab in Combination With Carboplatin Plus Etoposide to Investigate Safety and Efficacy in Patients With Untreated Extensive-Stage Small Cell Lung Cancer

Condition:   Small Cell Lung Carcinoma
Interventions:   Drug: Atezolizumab;   Drug: Carboplatin;   Drug: Etoposide
Sponsor:   Hoffmann-La Roche
Recruiting